Molecular Mechanisms of Aortic Valve Formation
Molecular Mechanisms of Aortic Valve Formation
批准号:
8915429
负责人:
Vidu Garg
金额:
$37.38万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2019-03-31
关键词:
AddressAgeAllelesBackcrossingsBicuspidCardiacCause of DeathCell LineageCellsComplexCongenital AbnormalityCongenital Heart DefectsCyclic GMPDataDefectDevelopmentDiseaseDisease modelEmbryoEndothelial CellsEndotheliumEpigenetic ProcessFamily StudyFunctional disorderGene ExpressionGene TargetingGenetic Predisposition to DiseaseHeartHeart Valve DiseasesHeart ValvesHeterozygoteHistologicHumanIncidenceInvestigationKnowledgeLeadMapsMesenchymalMesenchymeModelingMolecularMolecular AbnormalityMolecular AnalysisMorbidity - disease rateMorphogenesisMusMutant Strains MiceMutationMyocardialNOTCH1 geneNeural Crest CellNitric OxidePathogenesisPathway interactionsPhenotypePopulationPrevalencePrevention strategyPublic HealthPublicationsPublishingPulmonary valve structureReportingResearchSignal TransductionStagingStenosisSurgical ValvesTestingTransgenic Miceaortic valveaortic valve disorderbasebicuspid aortic valveclinically relevantcongenital heart disorderhuman NOS3 proteininfant deathmalformationmouse modelmutantnew therapeutic targetnotch proteinnovelpreventpublic health relevancesemilunar valvetreatment strategyvalve replacement
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Congenital heart disease is the most common type of birth defect and is the leading non-infectious cause of death in the first year of life. Malformations of the aortic valves are arguably the most common type of cardiac malformation as bicuspid aortic valve alone has an estimated prevalence of 1-2% in the population. The mechanisms underlying the development of aortic valve abnormalities are not well understood. We were the first to report that heterozygous mutations in NOTCH1 were associated with bicuspid aortic valve in humans but there remains a major void in our understanding of the mechanisms by which aortic valve malformations occur. We have generated a new mouse model of highly penetrant aortic valve malformations (bicuspid aortic valve) using Notch1 heterozygote mice backcrossed into a Nos3 (endothelial nitric oxide synthase)-null background. These mice display a near 100% incidence of aortic valve abnormalities including thickened, bicuspid and dysfunctional aortic valves. Our preliminary studies suggest that Nos3 genetically interacts with Notch1 in the valve endothelium to cause valve stenosis. Additional studies suggest that loss of Nos3 inhibits Notch1 signaling in endothelial cells to cause valve defects by an epigenetic mechanism. The overall hypothesis is that deficiency of Notch1 in endothelial cell lineages leads to BAV by disrupting the remodeling of developing aortic valve cushion mesenchyme. In this proposal, we will elucidate the cellular and molecular abnormalities in this clinically relevant model of aortic valve malformations. The specific aims of the proposal are: Specific Aim 1. To define the cellular and molecular mechanisms underlying the development of bicuspid aortic valve. Specific Aim 2. To determine the cell lineage requirement for Notch1 signaling for normal aortic valve morphogenesis. Specific Aim 3. To determine the mechanisms by which nitric oxide regulates Notch1 in the remodeling aortic valve.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Multi-omic approach towards improving candidate gene identification and variant prioritization in patients with congenital heart disease
-
批准号:10360965
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2022
-
负责人:Vidu Garg
-
依托单位:
A Multi-omic approach towards improving candidate gene identification and variant prioritization in patients with congenital heart disease
-
批准号:10544032
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2022
-
负责人:Vidu Garg
-
依托单位:
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations
-
批准号:9816152
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Vidu Garg
-
依托单位:
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations
-
批准号:10202715
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Vidu Garg
-
依托单位:
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations
-
批准号:10462586
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Vidu Garg
-
依托单位:
Weinstein Cardiovascular Development Conference
-
批准号:9261292
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2017
-
负责人:Vidu Garg
-
依托单位:
The Role of Notch in Calcific Aortic Valve Disease
-
批准号:9143866
-
项目类别:
-
资助金额:$67.71万
-
财政年份:2016
-
负责人:Vidu Garg
-
依托单位:
Exome sequencing and functional studies in familial CHD
-
批准号:8892228
-
项目类别:
-
资助金额:$64.95万
-
财政年份:2012
-
负责人:Vidu Garg
-
依托单位:
Exome sequencing and functional studies in familial CHD
-
批准号:8550126
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2012
-
负责人:Vidu Garg
-
依托单位:
Exome sequencing and functional studies in familial CHD
-
批准号:8297881
-
项目类别:
-
资助金额:$69.56万
-
财政年份:2012
-
负责人:Vidu Garg
-
依托单位:
Exome sequencing and functional studies in familial CHD
-
批准号:8708537
-
项目类别:
-
资助金额:$66.4万
-
财政年份:2012
-
负责人:Vidu Garg
-
依托单位:
Training in Congenital and Acquired Heart Disease
-
批准号:9766876
-
项目类别:
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:Vidu Garg
-
依托单位:
Training in Congenital and Acquired Heart Disease
-
批准号:9304327
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2009
-
负责人:Vidu Garg
-
依托单位:
Training in Congenital and Acquired Heart Disease
-
批准号:8935000
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2009
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7613484
-
项目类别:
-
资助金额:$15.05万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7981793
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7319005
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7793594
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7469434
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:8070520
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: